Quality control guidelines for susceptibility testing of retapamulin (SB-275833) by reference and standardized methods

被引:10
作者
Ross, JE [1 ]
Jones, RN [1 ]
机构
[1] JMI Labs Inc, N Liberty, IA 52317 USA
关键词
D O I
10.1128/JCM.43.12.6212-6213.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:6212 / 6213
页数:2
相关论文
共 9 条
[1]  
[Anonymous], 2003, NCCLS Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, V6th
[2]  
*CLIN LAB STAND I, 2005, DRUGS FUTURE, V25, P1163
[3]   Pleuromutilin antibiotics [J].
Hunt, E .
DRUGS OF THE FUTURE, 2000, 25 (11) :1163-1168
[4]   Tiamulin activity against fastidious and nonfastidious veterinary and human bacterial isolates: Initial development of in vitro susceptibility test methods [J].
Jones, RN ;
Pfaller, MA ;
Rhomberg, PR ;
Walter, DH .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (02) :461-465
[5]  
*NAT COMM CLIN LAB, 2003, M2A8 NCCLS
[6]  
*NAT COMM CLIN LAB, 2001, M23A2 NCCLS
[7]  
National Committee on Clinical Laboratory Standards, 2002, M31A2 NCCLS
[8]   Proposed quality control guidelines for National Committee for Clinical Laboratory Standards Susceptibility Tests using the veterinary antimicrobial agent tiamulin [J].
Pfaller, MA ;
Jones, RN ;
Walter, DH .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2001, 40 (1-2) :67-70
[9]  
Walsh C., 2003, ANTIBIOTICS ACTIONS, P237